[Fe

Xiao Wang, Jia-Hao Feng, Chun-Mei Zeng, Ze-Sheng Zhang, Feng-Lin Cao, Wen-Hua Zhang, Jin-Xiang Chen, David J Young

Abstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

A Nonanuclear Pd-Based Coordination Cage Featuring Ni-Chelated Porphyrin Ligand for Cancer Therapy via Combination of Chemodynamic and Photodynamic Modalities.Molecules (Basel, Switzerland) · 2026
Article
Thiazole Functionalization of Thiosemicarbazone for Cu(II) Complexation: Moving toward Highly Efficient Anticancer Drugs with Promising Oral Bioavailability.Molecules (Basel, Switzerland) · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao WangCollege of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China.

Jia-Hao FengNMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Chun-Mei ZengCollege of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China.

Ze-Sheng ZhangCollege of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China.

Feng-Lin CaoCollege of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China.

Wen-Hua ZhangCollege of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China.ORCID 0000-0001-9047-8881

Jin-Xiang ChenNMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

David J YoungGlasgow College UESTC, University of Electronic Science and Technology of China, Chengdu 611731, China.

Funding

National Natural Science Foundation of China 21871203Natural Science Foundation from Guangdong Science and Technology Department of China 2023A1515012633Project of Medical Innovation Application Research of Suzhou SKY2022094

6 · The paper itself

Abstract

Developing clinically meaningful nanomedicines for cancer therapy requires the drugs to be effective, safe, simple, cheap, and easy to store. In the present work, we report that a simple cationic Fe(III)-rich salt of [Fe

Indexed as

Antineoplastic AgentsFerroptosisNanomedicineCell Line, TumorCell SurvivalFerric CompoundsHumansHydrogen PeroxideNanoparticlesNeoplasmsTumor MicroenvironmentAntineoplastic AgentsFerric CompoundsHydrogen Peroxidebreast cancer therapychemodynamic therapyferroptosisporphyrin ligandsingle-molecular nanomedicine

Identifiers

PMID38893373

DOI10.3390/molecules29112495

PMCPMC11173869

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.